share_log

Nemaura Medical Announced That The Nasdaq Hearings Panel Granted The Company's Request For Continued Listing Under An Exception, Which Ultimately Expires On April 1 2024 - 8K

Nemaura Medical Announced That The Nasdaq Hearings Panel Granted The Company's Request For Continued Listing Under An Exception, Which Ultimately Expires On April 1 2024 - 8K

Nemaura Medical宣佈,納斯達克聽證會小組在例外情況下批准了該公司繼續上市的請求,該請求最終將於2024年4月1日到期-8K
Benzinga ·  2023/12/13 08:07
Nemaura Medical宣佈,納斯達克聽證會小組批准了該公司在例外情況下繼續上市的請求,該請求最終將於2024年4月1日到期-8K
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論